Pemirolast

From WikiMD's WELLNESSPEDIA

Pemirolast


Pemirolast is a mast cell stabilizer used in the treatment of allergic conjunctivitis and asthma. It is marketed under the trade names Alegysal and Alamast.

Pharmacology[edit]

Pemirolast functions as a mast cell stabilizer, inhibiting the release of histamine and other inflammatory mediators from mast cells. It does this by blocking the calcium channel essential for mast cell degranulation, preventing the release of these inflammatory mediators and thereby reducing the symptoms of allergic reactions.

Clinical Use[edit]

Pemirolast is used in the treatment of allergic conjunctivitis, a type of eye inflammation caused by allergies. It is also used in the management of asthma, particularly in cases where the condition is triggered by allergens.

Side Effects[edit]

Common side effects of Pemirolast include eye irritation, headache, and a bitter taste in the mouth. Rare but serious side effects can include severe allergic reactions.

Interactions[edit]

Pemirolast may interact with other drugs, particularly those that also affect the immune system. It is important to inform healthcare providers of all medications being taken to avoid potential interactions.

See Also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.